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http://dx.doi.org/10.1016/j.pedneo.2Background: Percutaneous endoscopic gastrostomy (PEG) is widely accepted as the preferred
procedure to establish long-term enteral feeding.
Objective: To learn the long-term outcomes of the patients who have undergone PEG place-
ment, we reviewed our experience with children who underwent this procedure in our insti-
tute.
Methods: A total of 83 pediatric patients (42 males and 41 females), who were aged from 3
months to 20 years, underwent PEG insertion in National Taiwan University Hospital from
January 2000 to April 2011. The underlying diseases of the patients receiving PEG were neuro-
logical dysfunction (nZ 67), metabolic disorders (nZ 9), gastrointestinal disease (nZ 2), and
congenital heart disease (nZ 1). This procedure was performed under intravenous sedation or
under general anesthesia. Prophylactic antibiotics were administered for 1 day. Tube feeding
began 24 hours after the PEG placement. The body weight of the patients was recorded 1 day
before PEG placement and at least 6 months after PEG placement.
Results: Theweight-for-ageZ-score before and at 6months after PEGplacementwere1.5 2.0
and 0.9  2.1, respectively, which was statistically significant (paired t test, pZ 0.006). The
catch-upgrowthwas recordedafterPEGplacement.ComplicationsofPEG inourpatients included
cellulitis at the gastrostomy wound (nZ 14), dislodgement of the tube (nZ 17), and persistent
gastrocutaneous fistula (nZ 3). The PEG tube was removed permanently in seventeen patients
because they resumed an adequate oral intake. During the follow-up period, 14 patients died of
an underlying disease or infection.
Conclusion: Our experience confirmed that PEG placement is a good long-term route for nutri-
tional supply with no serious complications in children.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.of Pediatrics, National Taiwan University Hospital, Number 8, Zhongshan S. Road, Zhongzheng Dis-
Y.-H. Ni).
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Outcome after PEG in Children 3271. Introduction inserted gastrostomy tube was used for clean water feedingChildren may require enteral tube feeding when they are
unable to swallow because of neurological or neuromus-
cular disorders or when they cannot maintain adequate
caloric intake because of congenital heart disease or
oncologic disease.1 Nasogastric (NG) tube feeding is
frequently employed under such conditions. However, the
long-term use of a NG tube may result in local nasopha-
ryngeal irritation and excess secretion production, thereby
increasing the risk of aspiration pneumonia. Other draw-
backs of NG feeding are easy dislocation with repeated
reinsertions of the tube, erosions and bleeding resulting
from trauma by the NG tube tips, and possible social
stigma. Since its introduction in 1980, percutaneous endo-
scopic gastrostomy (PEG) has been widely accepted as the
preferred route for enteral nutrition.2 It is relatively
noninvasive and less expensive than surgical gastrostomy.
The use of PEG can improve the nutritional status of pa-
tients3 and improve the quality of life of their caregivers.4,5
In this article, we reviewed the long-term outcomes of 83
children who underwent PEG placement in the Department
of Pediatrics in a tertiary hospital in Taiwan.
2. Methods
We performed a retrospective chart review of 83 patients
who underwent PEG placement in the Department of Pe-
diatrics of the National Taiwan University Hospital from
January 1, 2000 to April 30, 2011. Informed consent was
obtained.
The indications for PEG placement in the patients were
approved by multidisciplinary approaches. Before PEG
insertion, patients received serial evaluations such as an
upper gastrointestinal barium study, 99mTc gastric empty
time, and 24-hour esophageal pH monitoring (the multi-
channel intraluminal impedance was added in January
2010). Percutaneous endoscopic gastrostomy is the
preferred method for establishing an enteral nutrition
route in patients, except for patients who fit the exclusion
criteria, which includes severely prolonged gastric empty
time (i.e., more than 85% of the tracer remains in the
stomach after 1 hour), severe gastroesophageal reflux
(defined as a DeMeester score greater than 14.72), unfa-
vorable gastrointestinal anatomy, and limited life expec-
tancy. Under the aforementioned conditions, a surgeon
may shift to laparoscopic gastrostomy or abort this
procedure.
All patients received intravenous sedation or general
anesthesia during the procedure. We used a commercial-
ized PEG kit with the Ponsky Pull PEG kit (Bard Access
Systems, Inc, Salt Lake City, Utah, USA) or MIC PEG kit
(Kimberly-Clark, Roswell, Georgia, USA) with a Ponsky-pull
technique.6 After performing a diagnostic esophagogas-
troduodenoscopy, the stomach was fully inflated to push
the liver, spleen, and colon away from the gastrostomy
puncture site. The ideal position of gastrostomy is the
anterior wall of the middle or lower body. A dose of pro-
phylactic antibiotics, generally first generation cephalo-
sporin, was administered 30 minutes before the procedure.
Three doses were subsequently administered. Twenty-fourhours after the insertion of the PEG tube, the newly
and later for a liquid diet, if there were no complications.
Body weight was recorded 1 day before PEG tube
placement and at least 6 months after the insertion (6e9
months). The Z-score is the number of standard deviations
by which a weight differs from the mean weight at a spe-
cific age. The weight-for-age Z-score was calculated with
WHO Anthro v.3.2.2 software (World Health Organization,
Geneva, Switzerland) in patients who were younger than 5
years old and with WHO AnthroPlus v.1.0.4 software (World
Health Organization, Geneva, Switzerland) in patients who
were 5e10 years old. An increase in the weight-for-age
Z-score indicates “catch-up growth.”
The PEG was replaced with a low profile button device
(LPBD) or tube gastrostomy when long-term feeding support
was indicated. The tube gastrostomy that we used was the
CLINY flat balloon type (Create Medic Co., Hokkaido,
Japan), and the LPBD that we used was either the Bard
button device (Bard Access Systems, Inc, Salt Lake City,
Utah, USA) or the Cook low profile gastrostomy set (Wilson-
Cook Medical, Inc, Winston-Salem, North California, USA).
Patients received gastrostomy replacement at least 3
months after the PEG insertion. The chosen type was
decided after discussions with the caregivers, and the size
of PEG tube used was based on the patient’s body size.
Major events were recorded and included PEG tube
removal, PEG tube dislodgement, peristomal infection, and
mortality. The major complications were those that
required a surgical or endoscopic procedure, use of non-
prophylactic antibiotics, blood transfusion, or complica-
tions leading to death.73. Results
Eighty-three patients underwent PEG insertion from
January 1, 2000 to April 30, 2011. There were 42 males and
41 females. The mean follow-up period was 6.8 years per
person (range, 1e12.3 years). The mean age at gastrostomy
insertion was 4.6 years (range, 3 months to 20 years), and
14 (16.9%) patients were younger than 1 year old. The mean
weight at PEG insertion was 13.9 kg (range, 3.5e66.8 kg).
Sixty-seven (80.7%) of 83 patients were partially or fully
dependent on NG tube feeding at the time of PEG insertion.
Table 1 lists the underlying diseases of the patients.
The weight-for-age Z-score was 1.5  2.0 just before
PEG placement and 0.9  2.1 at 6 months later (paired t
test, p Z 0.006). There was an increase in the weight-for-
age Z-score after PEG placement, which indicates catch-up
growth after gastrostomy feeding.
The PEG was permanently removed from 17 (20.5%) of 83
patients in this study. The mean time interval between
insertion and removal was 1.42 years (range, 1.2 months to
2.6 years). The children who had the gastrostomy removed
were younger (mean age, 4 years) than children who
remained on PEG feeding (mean age, 4.7 years). Twelve of
the 17 patients showed improved oral intake ability and the
PEG tube was to be removed. The other five patients either
had an uncontrolled PEG wound infection (n Z 4) or an
unexpected gastrocutaneous tract closure due to prolonged
PEG dislodgement (nZ 1). After observation for a period of
Table 1 Underlying diseases of patients undergoing
percutaneous endoscopic gastrostomy insertion (N Z 83)
and permanent removal (N Z 17).
Diagnosis Insertion
N (%)
Removal
N (%)
Neurological dysfunction 67 (81) 9 (53)
Cerebral palsy 36 3
Hypoxic encephalopathy 8 1
Central nervous system infection 6 1
Seizure disorders 4
Metachromatic leukodystrophy 3
Mitochondria disease 2
Congenital varicella syndrome 1
de Lange syndrome 1 1
Ceroid lipofuscinosis 1
Encephalopathy with acute
psychosis
1 1
Neuromuscular disease 1
Intracerebral hemorrhage 1 1
Neurodegenerative disease 1 1
Congenital myopathy 1
Metabolic disorder 9 (11) 5 (29)
Niemann-Pick disease 2 1
Persistent hyperinsulinemic
hypoglycemia of infancy
2 2
Protein-induced hyperinsulinemic
hypoglycemia
1 1
Mucopolysaccharidosis 1
Nonketotic hyperglycinemia 1
Succinic semialdehyde
dehydrogenase deficiency
1 1
Maple syrup urine disorder 1
Gastrointestinal disease 2 (2) 2 (12)
Organoaxial gastric volvulus 1 1
Ineffective esophageal motility
disorder
1 1
Congenital heart disease 1 (1)
Coarctation of aorta, right
pulmonary artery hypoplasia
1
Others 4 (5) 1 (6)
Chromosome anomaly 2
Goldenhar syndrome 1 1
Neck lymphangioma 1
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tube could be removed permanently. Of the 17 patients,
nine patients [13.4% (9/67)] had a neurological dysfunction;
two patients had gastrointestinal diseases (1 patient with
gastric volvulus and 1 patient with ineffective esophageal
motility disorder); five patients had metabolic disorders (2
patients had persistent hyperinsulinemic hypoglycemia of
infancy; 1 patient had protein-induced hyperinsulinemic
hypoglycemia; 1 patient had Niemann-Pick disease; 1 pa-
tient had succinic semialdehyde dehydrogenase deficiency)
(Table 1). The patients with underlying gastrointestinal
disease had the highest chance of having the PEG removed
[100% (2/2)]. By contrast, most patients with a neurological
disorder needed lifelong enteral nutritional support. Three
(17.6%) of the 17 patients received operative gastrostomywound closure because of persistent gastrocutaneous fis-
tula. The mean time from PEG insertion until PEG removal
was 2.19 years (range, 1.96e2.62 years) for the three pa-
tients who experienced delayed closure of the gastro-
cutaneous fistula and 0.88 years (range, 0.1e1.44 years) for
patients with spontaneous closure of the fistula. The pa-
tients who had PEG placement for more than 1.5 years
seemed to have a greater likelihood of delayed closure of
the gastrocutaneous fistula.
Fifty-four patients received either a button type or a
balloon type gastrostomy tube replacement at least 3
months later. Manual traction was performed in all patients
for PEG removal. Two patients experienced bumper sepa-
ration and the inner dome remained in the stomach during
this procedure. A few days later, the dome passed un-
eventfully in both patients.
During the follow-up period, 20.5% (17/83) of patients
experienced gastrostomy tube dislodgement. The mean
duration between placement and dislodgement was 90 days
(range, 5e350 days). One patient had gastrocutaneous
tract stenosis and needed gastrostomy revision. Two pa-
tients had the complication of peritonitis and received
systemic antibiotics treatment. None of the patients pre-
sented with buried bumper syndrome.
Peristomal infection occurred in 14 patients with 22
episodes (0.12 episodes/1000 days of use) at a median in-
terval of 85.5 days (range, 3 days to 7.3 years) after PEG
placement. The most common pathogens from pus cultures
were mixed flora (n Z 13), followed by Pseudomonas aer-
uginosa (n Z 4), Candida species (n Z 2), Staphylococcus
aureus (n Z 2), and Enterobacter cloacae (n Z 1). The
mixed flora included Acinetobacter baumannii and Viridans
streptococci in one culture; S. aureus and P. aeruginosa
in three cultures; Klebsiella pneumoniae with E. cloacae in
one culture; K. pneumoniae with Serratia marcescens in
one culture; K. pneumoniae with S. aureus in one culture;
yeast-like organism with Escherichia coli in three cultures,
yeast-like organism with E. cloacae in one culture; yeast-
like organism with A. baumannii in one culture, and yeast-
like organism with Proteus in one culture. No peristomal
infection was associated with a positive blood culture. The
gastrostomy was removed in 3 patients because of signifi-
cant peristomal infection.
Fourteen (16.9%) of 83 patients died at a mean period of
3.43 years (range, 1.9 months to 9.9 years) after PEG
insertion. They died of underlying diseases that were
complicated by respiratory failure or septic shock. No death
was associated with the procedure.
The total major complication rate was 18.1%, according
to the previously mentioned definition.4. Discussion
According to the previous literature, PEG shortens the
hospital stay and it costs less than operative gastrostomy
(OG).8 The postoperative morbidity and severe gastro-
esophageal reflux were less frequent after PEG than after
OG in neurologically impaired children.9 Therefore, in 1994
we began performing PEG, rather than OG, in our institu-
tion when there were no contraindications.10 In infants and
children, PEG could be a safe method to establish enteral
Outcome after PEG in Children 329feeding.1,11 In our experience, the youngest patient was a
3-month-old girl with an atrial septal defect, supravavular
pulmonary stenosis, and organo-axial gastric volvulus. She
received laparoscopic-assisted PEG successfully. However,
the gastrostomy dislodged 5 days later because of poor
wound healing. After intensive wound care the gastrostomy
was reinserted 1 week later and thereafter remained in
place uneventfully. In adults with head and neck malig-
nancies, PEG is widely used for nutritional support; how-
ever, its use in children with malignancies is more limited,
possibly because of the increased risk of local infection and
poor wound healing if a child has a neutropenic status.12
Improvement in the nutritional status of patients
receiving PEG placement has been well established.3,12e14
Anthropometric measurements such as height, weight,
body mass index (BMI), triceps skin fold thickness (TSFT),
and mid-upper arm circumference (MAC) are the more
practical indices.14 Most of our patients have neurological
dysfunction and are bedridden, so height could not be
measured accurately. The weight-for-age is an ideal and
easy parameter. Our study showed an increase in the
weight-for-age Z-score after PEG placement, which in-
dicates catch-up growth after gastrostomy feeding.
Long-term NG tube use may interfere with the training
of the swallowing ability; therefore, PEG could be used as a
temporary route of enteral feeding during a rehabilitation
program. In this study, PEG was permanently removed from
17 (20.5%) of 83 patients. A persistent gastrocutaneous
fistula is a fistula between the stomach and the skin that
has not closed by one month after the removal of the gas-
trostomy tube. The medical literature indicates that the
time between the insertion and the removal of the gas-
trostomy is the only factor that determines whether a
gastrocutaneous fistula will persist. Our results were
compatible with previous findings. In our experience, the
patients who had PEG placement for more than 1.5 years
seemed to have a greater likelihood of delayed closure of
the gastrocutaneous fistula and therefore surgical closure
may be expected. The age of a patient at the time of PEG
insertion, the underlying disease, and the type of gastro-
stomy tube showed no conclusive correlation with the
persistence of gastrocutaneous fistula.15,16
Stoma-related complications were common and included
infection, granulation, and leakage. The complication rate
was high, but most complications were minor and easy to
treat.5 The prophylactic use of antibiotics could prevent the
complication of peristomal infection. However, the type of
prophylactic antibiotics used and the number of doses
needed showed no significant differences.1
A previous report showed that the rate of major compli-
cations was approximately 12.6e17.5% for complications
requiring an unexpected surgical or endoscopic procedure,
nonprophylactic antibiotics use or blood transfusion, and
complications leading to death.7 Percutaneous endoscopic
gastrostomy procedure-related mortality is rare. The inci-
dence is 0.5e1.2%, according to the medical literature.1 In
our experience, the rate of major complications was 18.1%,
and most (16.9%) of these complications were peristomal
infections that necessitated antibiotics use. No procedure-related mortality occurred in our study group. In conclu-
sion, our experience suggested that PEG is a safe procedure
that can provide long-term nutritional support with accept-
able complication rates in children.References
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